Letters sent to healthcare professionals in June 2015

Last month, letters sent included one for the oral anticoagulant edoxaban.

From:
Medicines and Healthcare products Regulatory Agency
Published
20 July 2015

In each issue of Drug Safety Update we summarise drug safety letters sent to healthcare professionals that are not linked to their own Drug Safety Update article. In June 2015, letters sent included one for the oral anticoagulant edoxaban.

Article citation: Drug Safety Update volume 8 issue 12 July 2015: 4.

Updates to this page

Published 20 July 2015